JP2004531547A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004531547A5 JP2004531547A5 JP2002588973A JP2002588973A JP2004531547A5 JP 2004531547 A5 JP2004531547 A5 JP 2004531547A5 JP 2002588973 A JP2002588973 A JP 2002588973A JP 2002588973 A JP2002588973 A JP 2002588973A JP 2004531547 A5 JP2004531547 A5 JP 2004531547A5
- Authority
- JP
- Japan
- Prior art keywords
- collagen
- pharmaceutical composition
- methylsulfoxy
- group
- groups
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Withdrawn
Links
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US09/858,247 US6673370B2 (en) | 2001-05-15 | 2001-05-15 | Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| PCT/US2002/000507 WO2002092055A1 (en) | 2001-05-15 | 2002-01-17 | Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2004531547A JP2004531547A (ja) | 2004-10-14 |
| JP2004531547A5 true JP2004531547A5 (enExample) | 2005-09-15 |
Family
ID=25327854
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002588973A Withdrawn JP2004531547A (ja) | 2001-05-15 | 2002-01-17 | 非適合性医薬剤と一緒に用いるための酸化されたコラーゲンの製剤 |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US6673370B2 (enExample) |
| EP (1) | EP1395244A1 (enExample) |
| JP (1) | JP2004531547A (enExample) |
| CA (1) | CA2447574A1 (enExample) |
| WO (1) | WO2002092055A1 (enExample) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB0011903D0 (en) * | 2000-05-18 | 2000-07-05 | Astrazeneca Ab | Combination chemotherapy |
| US6673370B2 (en) * | 2001-05-15 | 2004-01-06 | Biomedicines, Inc. | Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
| CN1922187A (zh) * | 2004-01-15 | 2007-02-28 | 新南创新有限公司 | 由葫芦形联脲[7－12]部分包封的多核金属配合物 |
| US8168662B1 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8178564B2 (en) | 2006-11-06 | 2012-05-15 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8173686B2 (en) | 2006-11-06 | 2012-05-08 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US8168661B2 (en) | 2006-11-06 | 2012-05-01 | Poniard Pharmaceuticals, Inc. | Use of picoplatin to treat colorectal cancer |
| US20110033528A1 (en) * | 2009-08-05 | 2011-02-10 | Poniard Pharmaceuticals, Inc. | Stabilized picoplatin oral dosage form |
| TW200916094A (en) * | 2007-06-27 | 2009-04-16 | Poniard Pharmaceuticals Inc | Stabilized picoplatin dosage form |
| US20100260832A1 (en) * | 2007-06-27 | 2010-10-14 | Poniard Pharmaceuticals, Inc. | Combination therapy for ovarian cancer |
| TW200920347A (en) * | 2007-07-16 | 2009-05-16 | Poniard Pharmaceuticals Inc | Oral formulations for picoplatin |
| WO2009099651A1 (en) * | 2008-02-08 | 2009-08-13 | Poniard Pharmaceuticals, Inc. | Use of picoplatin and cetuximab to treat colorectal cancer |
| KR101341732B1 (ko) | 2010-01-28 | 2013-12-20 | 전남대학교산학협력단 | 난소암 진단을 위한 콜라겐 유형 ⅵ 알파 １의 신규한 용도 |
| AU2011232414A1 (en) | 2010-03-24 | 2012-11-15 | Covidien Lp | Combination three-dimensional surgical implant |
| KR101158338B1 (ko) * | 2010-05-14 | 2012-06-22 | (주)다림티센 | 아텔로콜라겐 분리방법 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4619913A (en) | 1984-05-29 | 1986-10-28 | Matrix Pharmaceuticals, Inc. | Treatments employing drug-containing matrices for introduction into cellular lesion areas |
| US5013553A (en) | 1987-06-30 | 1991-05-07 | Vipont Pharmaceutical, Inc. | Drug delivery devices |
| DE3937076A1 (de) * | 1989-11-07 | 1991-05-08 | Heyl Chem Pharm | Kollagene, verfahren zu ihrer herstellung und kosmetische mittel |
| GB9206504D0 (en) * | 1992-03-25 | 1992-05-06 | Jevco Ltd | Heteromorphic sponges as wound implants |
| US5750146A (en) | 1995-04-28 | 1998-05-12 | Matrix Pharmaceutical, Inc. | Translucent collagen formulations with a cytotoxic drug |
| GB2314842B (en) * | 1996-06-28 | 2001-01-17 | Johnson & Johnson Medical | Collagen-oxidized regenerated cellulose complexes |
| US6673370B2 (en) * | 2001-05-15 | 2004-01-06 | Biomedicines, Inc. | Oxidized collagen formulations for use with non-compatible pharmaceutical agents |
-
2001
- 2001-05-15 US US09/858,247 patent/US6673370B2/en not_active Expired - Fee Related
-
2002
- 2002-01-17 CA CA002447574A patent/CA2447574A1/en not_active Abandoned
- 2002-01-17 JP JP2002588973A patent/JP2004531547A/ja not_active Withdrawn
- 2002-01-17 EP EP02703088A patent/EP1395244A1/en not_active Withdrawn
- 2002-01-17 WO PCT/US2002/000507 patent/WO2002092055A1/en not_active Ceased
-
2003
- 2003-09-04 US US10/656,657 patent/US7011851B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2004531547A5 (enExample) | ||
| Sadler et al. | Metal complexes in medicine: design and mechanism of action | |
| JP2005515191A5 (enExample) | ||
| Sen et al. | Copper-induced vascular endothelial growth factor expression and wound healing | |
| US8877231B2 (en) | Anti-microbial dental formulations for the prevention and treatment of oral mucosal disease | |
| MX2013001749A (es) | Composiciones y metodos para tratar enfermedades cardiovasculares. | |
| ATE98245T1 (de) | Azaindene. | |
| KR870009717A (ko) | 신규 경구용 약제 | |
| CN110585237A (zh) | 一种纳米诊疗剂及其制备方法、应用 | |
| CN114533660A (zh) | 一种牙周局部递送制剂、其制备方法及应用 | |
| JP7299876B2 (ja) | 病原性感染の処置のための組成物及び処置手順 | |
| Rich et al. | Severe complications of intravenous phytonadione therapy: two cases, with one fatality | |
| JP2004531547A (ja) | 非適合性医薬剤と一緒に用いるための酸化されたコラーゲンの製剤 | |
| DE69414521D1 (de) | Verfahren zur herstellung von iodierten biopolymeren mit desinfizierender und vernarbungsfördernder wirkung und darnach hergestellte iodierte biopolymeren | |
| Perrin | Medicinal chemistry | |
| RU2261243C1 (ru) | Соли цинка и галоидкарбоновых кислот алифатического ряда для лечения новообразований кожи и видимых слизистых покровов | |
| JP2009514786A5 (enExample) | ||
| ES2655238T3 (es) | Un proceso para producir complejos de caseína N-acetil-aspartilada y hierro (III) y uso de los mismos en composiciones farmacéuticas | |
| US11548792B2 (en) | Water-soluble gold (III) complexes, methods of producing water-soluble gold (III) complexes and their use | |
| CN1079391A (zh) | 用于癌病灶直接给药的砷制剂的制备方法 | |
| JP6041811B2 (ja) | 細菌由来の感染症を治療する抗細菌剤 | |
| WO2022023847A1 (pt) | Gel clareador dental compreendendo compostos de nióbio modificados, processo e uso | |
| WO2017185060A1 (en) | Oral iodine dosage form | |
| Fakhroueian et al. | The mirror strategy of nanoparticles against the coronavirus | |
| PL244960B1 (pl) | Zastosowanie rozpuszczalnych w wodzie kompleksów złota (III) |